Skip to main content
Journal cover image

The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota.

Publication ,  Journal Article
Boursier, J; Mueller, O; Barret, M; Machado, M; Fizanne, L; Araujo-Perez, F; Guy, CD; Seed, PC; Rawls, JF; David, LA; Hunault, G; Oberti, F ...
Published in: Hepatology
March 2016

UNLABELLED: Several animal studies have emphasized the role of gut microbiota in nonalcoholic fatty liver disease (NAFLD). However, data about gut dysbiosis in human NAFLD remain scarce in the literature, especially studies including the whole spectrum of NAFLD lesions. We aimed to evaluate the association between gut dysbiosis and severe NAFLD lesions, that is, nonalcoholic steatohepatitis (NASH) and fibrosis, in a well-characterized population of adult NAFLD. Fifty-seven patients with biopsy-proven NAFLD were enrolled. Taxonomic composition of gut microbiota was determined using 16S ribosomal RNA gene sequencing of stool samples. Thirty patients had F0/F1 fibrosis stage at liver biopsy (10 with NASH), and 27 patients had significant F≥2 fibrosis (25 with NASH). Bacteroides abundance was significantly increased in NASH and F≥2 patients, whereas Prevotella abundance was decreased. Ruminococcus abundance was significantly higher in F≥2 patients. By multivariate analysis, Bacteroides abundance was independently associated with NASH and Ruminococcus with F≥2 fibrosis. Stratification according to the abundance of these two bacteria generated three patient subgroups with increasing severity of NAFLD lesions. Based on imputed metagenomic profiles, Kyoto Encyclopedia of Genes and Genomes pathways significantly related to NASH and fibrosis F≥2 were mostly related to carbohydrate, lipid, and amino acid metabolism. CONCLUSION: NAFLD severity associates with gut dysbiosis and a shift in metabolic function of the gut microbiota. We identified Bacteroides as independently associated with NASH and Ruminococcus with significant fibrosis. Thus, gut microbiota analysis adds information to classical predictors of NAFLD severity and suggests novel metabolic targets for pre-/probiotics therapies.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Hepatology

DOI

EISSN

1527-3350

Publication Date

March 2016

Volume

63

Issue

3

Start / End Page

764 / 775

Location

United States

Related Subject Headings

  • Non-alcoholic Fatty Liver Disease
  • Middle Aged
  • Metagenome
  • Male
  • Liver
  • Humans
  • Gastrointestinal Microbiome
  • Gastroenterology & Hepatology
  • Fibrosis
  • Female
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Boursier, J., Mueller, O., Barret, M., Machado, M., Fizanne, L., Araujo-Perez, F., … Diehl, A. M. (2016). The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota. Hepatology, 63(3), 764–775. https://doi.org/10.1002/hep.28356
Boursier, Jérôme, Olaf Mueller, Matthieu Barret, Mariana Machado, Lionel Fizanne, Felix Araujo-Perez, Cynthia D. Guy, et al. “The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota.Hepatology 63, no. 3 (March 2016): 764–75. https://doi.org/10.1002/hep.28356.
Boursier J, Mueller O, Barret M, Machado M, Fizanne L, Araujo-Perez F, et al. The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota. Hepatology. 2016 Mar;63(3):764–75.
Boursier, Jérôme, et al. “The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota.Hepatology, vol. 63, no. 3, Mar. 2016, pp. 764–75. Pubmed, doi:10.1002/hep.28356.
Boursier J, Mueller O, Barret M, Machado M, Fizanne L, Araujo-Perez F, Guy CD, Seed PC, Rawls JF, David LA, Hunault G, Oberti F, Calès P, Diehl AM. The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota. Hepatology. 2016 Mar;63(3):764–775.
Journal cover image

Published In

Hepatology

DOI

EISSN

1527-3350

Publication Date

March 2016

Volume

63

Issue

3

Start / End Page

764 / 775

Location

United States

Related Subject Headings

  • Non-alcoholic Fatty Liver Disease
  • Middle Aged
  • Metagenome
  • Male
  • Liver
  • Humans
  • Gastrointestinal Microbiome
  • Gastroenterology & Hepatology
  • Fibrosis
  • Female